Literature DB >> 26797799

Expression of the anti-inflammatory suppressor of cytokine signaling 3 (SOCS3) in human clear cell renal cell carcinoma.

Anja Urbschat1, Svenja Stumpf2, Jörg Hänze2, Patrick Paulus3, Thorsten J Maier4, Christine Weipert5, Rainer Hofmann2, Axel Hegele2.   

Abstract

The oncogenic transcription factor signal transducer and activator of transcription 3 (STAT3) is a cytokine-activated transcription factor controlling inflammation, cell proliferation, survival, and differentiation in normal tissue as well as in tumor growth. One of its most important negative regulators is the suppressor of cytokine signaling 3 (SOCS3). Here, we analyzed SOCS3 and other tumor-associated local immune regulators in human clear cell renal cell carcinoma (ccRCC). Analyses were performed in tumor and adjacent tumor-free healthy renal tissue from 35 patients with ccRCC. For functional analysis, ccRCC Caki-1 cell lines were stimulated with IL-6 and IFNγ in cell culture assays. We observed significantly lower SOCS3 messenger RNA (mRNA) levels in tumor tissue compared to healthy tissue. SOCS3 mRNA strongly correlated within tumor and healthy tissue. Interestingly vice versa, SOCS3 protein levels were significantly higher in tumor tissue than in healthy tissue. IL-22 and IL-22R1 mRNA displayed no differences in tumor and healthy tissue. Stimulation of Caki-1 cells with IFNγ resulted in markedly increased SOCS3 mRNA levels. We conclude that SOCS3 along with STAT3 participates in regulatory mechanisms in ccRCC, which certainly features only one of multiple factors involved but nevertheless merits further attention.

Entities:  

Keywords:  Clear cell renal cell carcinoma; JAK2; SOCS3; STAT3

Mesh:

Substances:

Year:  2016        PMID: 26797799     DOI: 10.1007/s13277-016-4857-9

Source DB:  PubMed          Journal:  Tumour Biol        ISSN: 1010-4283


  31 in total

Review 1.  Negative regulation of cytokine signaling pathways.

Authors:  H Yasukawa; A Sasaki; A Yoshimura
Journal:  Annu Rev Immunol       Date:  2000       Impact factor: 28.527

2.  Low expression of SOCS-1 and SOCS-3 is a poor prognostic indicator for gastric cancer patients.

Authors:  Guanghua Li; Jianbo Xu; Zhao Wang; Yujie Yuan; Yin Li; Shirong Cai; Yulong He
Journal:  J Cancer Res Clin Oncol       Date:  2014-09-28       Impact factor: 4.553

3.  Induction of the cytokine signal regulator SOCS3/CIS3 as a therapeutic strategy for treating inflammatory arthritis.

Authors:  T Shouda; T Yoshida; T Hanada; T Wakioka; M Oishi; K Miyoshi; S Komiya; K Kosai; Y Hanakawa; K Hashimoto; K Nagata; A Yoshimura
Journal:  J Clin Invest       Date:  2001-12       Impact factor: 14.808

4.  SOCS-3 inhibits IL-12-induced STAT4 activation by binding through its SH2 domain to the STAT4 docking site in the IL-12 receptor beta2 subunit.

Authors:  Koh Yamamoto; Mitsuko Yamaguchi; Nobuyuki Miyasaka; Osamu Miura
Journal:  Biochem Biophys Res Commun       Date:  2003-10-31       Impact factor: 3.575

5.  STAT3 inhibitor WP1066 as a novel therapeutic agent for renal cell carcinoma.

Authors:  A Horiguchi; T Asano; K Kuroda; A Sato; J Asakuma; K Ito; M Hayakawa; M Sumitomo; T Asano
Journal:  Br J Cancer       Date:  2010-05-11       Impact factor: 7.640

6.  Histopathology and classification of renal cell tumors (adenomas, oncocytomas and carcinomas). The basic cytological and histopathological elements and their use for diagnostics.

Authors:  W Thoenes; S Störkel; H J Rumpelt
Journal:  Pathol Res Pract       Date:  1986-05       Impact factor: 3.250

7.  Adaptive immunity maintains occult cancer in an equilibrium state.

Authors:  Catherine M Koebel; William Vermi; Jeremy B Swann; Nadeen Zerafa; Scott J Rodig; Lloyd J Old; Mark J Smyth; Robert D Schreiber
Journal:  Nature       Date:  2007-11-18       Impact factor: 49.962

Review 8.  STATs in cancer inflammation and immunity: a leading role for STAT3.

Authors:  Hua Yu; Drew Pardoll; Richard Jove
Journal:  Nat Rev Cancer       Date:  2009-11       Impact factor: 60.716

9.  Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012.

Authors:  Jacques Ferlay; Isabelle Soerjomataram; Rajesh Dikshit; Sultan Eser; Colin Mathers; Marise Rebelo; Donald Maxwell Parkin; David Forman; Freddie Bray
Journal:  Int J Cancer       Date:  2014-10-09       Impact factor: 7.396

10.  Human and murine kidneys show gender- and species-specific gene expression differences in response to injury.

Authors:  Han Si; Ramandeep S Banga; Pinelopi Kapitsinou; Manjunath Ramaiah; Janis Lawrence; Ganesh Kambhampati; Antje Gruenwald; Erwin Bottinger; Daniel Glicklich; Vivian Tellis; Stuart Greenstein; David B Thomas; James Pullman; Melissa Fazzari; Katalin Susztak
Journal:  PLoS One       Date:  2009-03-11       Impact factor: 3.240

View more
  1 in total

1.  [Role of cytokine signal suppressor 3 in the regulatory mechanism of colon cancer invasion and proliferation].

Authors:  Zhu Hong; Xipeng Zhang
Journal:  Nan Fang Yi Ke Da Xue Xue Bao       Date:  2019-01-30
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.